Intelligence / Healthtech / New Clinical Trials / Mitra Bio
Clinicaltrial registered20 Oct 2026
Mitra Bio
20 Oct 2026: Trial registered · Development and Multi-Centre Validation of a Novel Non-Invasive Melanoma Molecular Diagnostic Test. Recorded in the ClinicalTrials.gov (US National Library of Medicine).
- Posted
- 20 Oct 2026
- Title
- Development and Multi-Centre Validation of a Novel Non-Invasive Melanoma Molecular Diagnostic Test
- Conditions
- Melanoma
- Study Type
- Observational
- Status
- Recruiting
- Countries
- Belgium, Germany, Spain, United Kingdom
- Country
- Belgium
- Reference
- NCT07883954
- Location
- Belgium, Germany, Spain
What this signal means
A new trial needs sites, patients, data capture, monitoring and regulatory partners for years.
- United States leads with 192 of 777, then China (171).
- 777 added in the 30 days to 18 Nov 2026.
Reach them with AOS
Find the decision makers at Mitra Bio
AOS maps the buying committee, finds verified work emails and drafts outreach that cites this clinical signal, for your approval.
More from Belgium
New Clinical Trials
10 NovBoehringer Ingelheimtrial registered · A Study to Test Obrixtamig Treatment in People With Different Types of Advanced Cancer Who Took Part in a Previous Study With ObrixtamigClinical9 NovBoehringer Ingelheimtrial registered · A Study to Test Whether BI 3810477 Helps People With Idiopathic Pulmonary Fibrosis When Taken With or Without Standard TreatmentClinical5 NovNovo Nordisk A/Strial registered · A Research Study to Investigate How Well the Medicine CagriSema Lowers High Blood Pressure in People Living With High Blood Pressure and ObesityClinical4 NovBoehringer Ingelheimtrial registered · A Study to Learn How Well People With Bronchiectasis Tolerate Continued Treatment With Verducatib After Earlier Studies (AIRTIVITY®-ON)Clinical28 OctMED-EL Elektromedizinische Geräte GmbHtrial registered · Mi2000 TICI Follow-upClinical27 OctMED-EL Elektromedizinische Geräte GmbHtrial registered · Mi2000 TICI - Post-market Implantation StudyClinical
Source: ClinicalTrials.gov (US National Library of Medicine), data to 18 Nov 2026. Trials first posted in the window whose lead sponsor is a company, worldwide. Device and diagnostic studies usually have no phase. AOS shows what the public record says; it does not verify or endorse the company.